| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2022-03-07 02:49:02 UTC |
|---|
| HMDB ID | HMDB0000412 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 3beta,17alpha-Dihydroxy-5alpha-androstane |
|---|
| Description | 3beta,17alpha-Dihydroxy-5alpha-androstane is a steroid found in the monosulfate fraction of normal human feces. Several steroids identified in the disulfate fraction of human bile are found in the monosulfate fraction of human feces, indicating partial hydrolysis of diconjugates in the intestine. The androstanediols and pregnanediols found in the feces are primarily of a 3beta-hydroxy-5alpha- or 3beta-hydroxy-5beta-structure, whereas those in the bile are of a 3alpha-hydroxy-5alpha- or 3alpha-hydroxy-5beta-structure. This suggests the conversion of a 3alpha-hydroxyl to a 3beta-hydroxyl in the intestine in vivo. 3beta,17alpha-Dihydroxy-5alpha-androstane is also found unconjugated in normal human plasma (PMID: 4245755 , 4223807 , 4321841 , 1769135 ). |
|---|
| Structure | [H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17+,18-,19-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 5-ALPHA-ANDROSTANE-3-BETA,17-ALPHA-diol | ChEBI | | 5-a-ANDROSTANE-3-b,17-a-diol | Generator | | 5-Α-androstane-3-β,17-α-diol | Generator | | 3b,17a-Dihydroxy-5a-androstane | Generator | | 3Β,17α-dihydroxy-5α-androstane | Generator | | 5 Androstane 3,17 diol | HMDB | | 5 alpha Androstane 3 alpha,17 beta diol | HMDB | | 5 alpha Androstane 3 beta,17 alpha diol | HMDB | | 5 alpha Androstane 3 beta,17 beta diol | HMDB | | 5 alpha Androstane 3alpha,17 beta diol | HMDB | | 5 alpha-Androstane-3 alpha,17 beta-diol | HMDB | | 5 alpha-Androstane-3 beta,17 alpha-diol | HMDB | | 5 alpha-Androstane-3 beta,17 beta-diol | HMDB | | 5 alpha-Androstane-3alpha,17 beta-diol | HMDB | | 5 beta Androstane 3 alpha,17 beta diol | HMDB | | 5 beta-Androstane-3 alpha,17 beta-diol | HMDB | | 5-Androstane-3,17-diol | HMDB | | 5alpha Androstane 3beta,17alpha diol | HMDB | | 5alpha-Androstane-3beta,17alpha-diol | HMDB | | Androstane 3,17 diol | HMDB | | Androstane-3,17-diol | HMDB | | 5a-Androstane-3b,17a-diol | HMDB | | 5Α-androstane-3β,17α-diol | HMDB | | (3beta,5alpha,17alpha)-Androstane-3,17-diol | HMDB | | (3Β,5α,17α)-androstane-3,17-diol | HMDB | | 5alpha-Androstan-3beta,17alpha-diol | HMDB | | 5Α-androstan-3β,17α-diol | HMDB | | 3beta,17alpha-Dihydroxy-5alpha-androstane | HMDB |
|
|---|
| Chemical Formula | C19H32O2 |
|---|
| Average Molecular Weight | 292.4562 |
|---|
| Monoisotopic Molecular Weight | 292.240230268 |
|---|
| IUPAC Name | (1S,2S,5S,7S,10R,11S,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol |
|---|
| Traditional Name | (1S,2S,5S,7S,10R,11S,14R,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5,14-diol |
|---|
| CAS Registry Number | 5856-11-1 |
|---|
| SMILES | [H][C@@]12CC[C@@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C |
|---|
| InChI Identifier | InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17+,18-,19-/m0/s1 |
|---|
| InChI Key | CBMYJHIOYJEBSB-MFXFBURESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Androstane steroids |
|---|
| Direct Parent | Androgens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Androgen-skeleton
- 17-hydroxysteroid
- 3-beta-hydroxysteroid
- Hydroxysteroid
- 3-hydroxysteroid
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 5.94 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.4283 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.24 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 68.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2466.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 317.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 195.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 175.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 472.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 623.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 599.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 116.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1114.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 449.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1497.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 355.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 415.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 312.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 375.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 43.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3beta,17alpha-Dihydroxy-5alpha-androstane,1TMS,isomer #1 | C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@H]2O[Si](C)(C)C | 2563.9 | Semi standard non polar | 33892256 | | 3beta,17alpha-Dihydroxy-5alpha-androstane,1TMS,isomer #2 | C[C@]12CC[C@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@H]2O | 2552.9 | Semi standard non polar | 33892256 | | 3beta,17alpha-Dihydroxy-5alpha-androstane,2TMS,isomer #1 | C[C@]12CC[C@H](O[Si](C)(C)C)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@H]2O[Si](C)(C)C | 2573.3 | Semi standard non polar | 33892256 | | 3beta,17alpha-Dihydroxy-5alpha-androstane,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C | 2857.1 | Semi standard non polar | 33892256 | | 3beta,17alpha-Dihydroxy-5alpha-androstane,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@H]2O)C1 | 2820.7 | Semi standard non polar | 33892256 | | 3beta,17alpha-Dihydroxy-5alpha-androstane,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@@H]3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@H]2O[Si](C)(C)C(C)(C)C)C1 | 3133.6 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Positive-QTOF | splash10-004l-0090000000-22d60c19836ea8b4c291 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Positive-QTOF | splash10-056r-0390000000-edb0fb77b27575b4b729 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Positive-QTOF | splash10-00mk-2980000000-cd6eafa93f3164ed780a | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Negative-QTOF | splash10-0006-0090000000-bc689c3cdfdf044c011e | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Negative-QTOF | splash10-006x-0090000000-bfbc140857bbdb62bcff | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Negative-QTOF | splash10-06vm-1290000000-bced1e06a8686f3501af | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Negative-QTOF | splash10-0006-0090000000-11452f48ce72555f1f28 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Negative-QTOF | splash10-0006-0090000000-11452f48ce72555f1f28 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Negative-QTOF | splash10-000l-0090000000-ac9e93370094e8aebfa1 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 10V, Positive-QTOF | splash10-002f-0090000000-36f4d97265b0d994d628 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 20V, Positive-QTOF | splash10-052b-3940000000-b87bad8b672cc5fb32b0 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3beta,17alpha-Dihydroxy-5alpha-androstane 40V, Positive-QTOF | splash10-0aos-3900000000-0f8ce10c286f165d6e0f | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|